**Author details**

Yaser Alahamd1 \*, Hisham Ab Ib Swehli<sup>2</sup> , Alaa Rahhal3 , Sundus Sardar2 , Mawahib Ali Mohammed Elhassan1 , Salma Alsamel4 and Osama Ali Ibrahim1

1 Cardiology Department, Heart Hospital, Hamad Medical Corporation, Doha, Qatar

2 Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar

3 Pharmacy Department, Heart Hospital, Hamad Medical Corporation, Doha, Qatar

4 Military Medical Specialty Center, Doha, Qatar

\*Address all correspondence to: yalahmad@hamad.qa

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**233**

2011

*Calcium Channel Blockers*

Hypertension. 2017:**71**:e13

[2] James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA.

[3] Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology

(ESC). Journal of Hypertens.

[4] Hart P, Bakris GL. Calcium antagonists: Do they equally protect against kidney injury? Kidney International. 2008;**73**:795

[5] Brunton LL, Hilal-Dandan R, Knollmann BC. Goodman & Gilman's:

[6] Waller D, Sampson A. Medical Pharmacology and Therapeutics. 5th ed. Amsterdam: Elsevier Limited; 2018

[7] Beale JM, Block JH. Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry. 12th ed. Philadelphia: Lippincott Williams & Wilkins, a Wolters Kluwer Business;

Therapeutics, 13e. New York: McGraw-

The Pharmacological Basis of

Hill Education; 2018

**References**

2014;**311**:507

2013;**31**:1281

*DOI: http://dx.doi.org/10.5772/intechopen.90778*

[1] Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/ American Heart Association task force on clinical practice guidelines.

[8] Golan DE, Tashjian AH,

[9] Hamm CW, Bassand JP,

[10] Anderson JL, Adams CD, Antman EM, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/ American Heart Association task force on practice guidelines. Circulation.

[11] de Weert TT, Cakir H, Rozie S, Cretier S, Meijering E, Dippel DW, et al. Intracranial internal carotid artery calcifications: Association with vascular risk factors and ischemic cerebrovascular disease. AJNR. American Journal of Neuroradiology. 2009;**30**:177-184

[12] Power A, Chan K, Haydar A, Hamady M, Cairns T, Taube D, et al. Intracranial arterial calcification is highly prevalent in hemodialysis patients but does not associate with acute ischemic stroke. Hemodialysis International. 2011;**15**:256-263

[13] Bos D, van der Rijk MJ,

Geeraedts TE, Hofman A, Krestin GP,

2017

2011;**32**:2999

2011;**123**:e426

Armstrong EJ, April W. Armstrong Principles of Pharmacology: The

Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The task force for the Management of Acute Coronary

Syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal.

Pathophysiologic Basis of Drug Therapy. 4th ed. South Holland: Wolters Kluwer;
